Happy Rheumatoid Awareness Day! 💙 Rheumatoid disease is an autoimmune condition. The body believes the linings of the joints are foreign tissue, which causes the body to attack and damage the joints. This results in inflammation and pain, with arthritis being a major symptom of the #Rheumatoid disease. This disease affects more than a million Americans, most of them being women. #RheumatoidAwareness Day was created in 2013 to help raise awareness for the disease. Research has shown that a lack of public education and awareness, leads to a delay in seeking medical advice which can result in inadequate treatment. Click here https://bit.ly/3w5zQEY to check out our currently open Rheumatoid clinical trials!
UCI Center for Clinical Research’s Post
More Relevant Posts
-
The collaborative efforts led by Prof. Schett play a crucial role in instilling renewed optimism for individuals coping with severe rheumatological autoimmune diseases. Furthermore, these endeavors pave the path for multi-center clinical studies, aiming to conclusively establish the safety and effectiveness of CAR T-cell therapies in autoimmune diseases driven by B cells. #celltherapy #autoimmunediseases #biopharma https://lnkd.in/eKuguk2E
-
-
Overcoming complexities to rapidly advance your metabolic disease treatments to market ⏩ Clinical research for metabolic and endocrine diseases is a rising area of focus due to the growing demand for novel therapies that demonstrate safety and efficacy. In the past five years, our team has supported 200+ projects for endocrine/metabolic disorder treatments and prepared 20+ marketing applications. Developing endocrine or metabolic therapy? Learn more 👇 https://bit.ly/3O48Z1V #EndocrineMetabolicDisease #ClinicalResearch #MetabolicTherapy
-
In this MEDtalk, Astrid Damgaard presents a study that aimed to validate the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires (BRAF-MDQ and BRAF-NRS) for patients with spondyloarthritis. The results showed that these questionnaires are reliable and valid tools for measuring fatigue in this patient group, with good content validity, internal consistency, and test-retest reliability. #RheumatoidArthritis #SpA #Treatments
Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs
https://bpno.se
-
Monitoring disease activity: ARA Standard 5 Explained for Physiotherapists! Uncover Quality Statement 5 of the Australian Rheumatoid Arthritis Clinical Care Standard. Discover the significance of ongoing disease activity monitoring in achieving treatment goals and optimising health outcomes. Subscribe for insights on effectively monitoring disease activity in rheumatoid arthritis care! Brought to you by Hello jp "About the ARA Standard of Care for Rheumatoid Arthritis" www.rheumatology.org.au #Physiotherapy #RheumatoidArthritis #DiseaseMonitoring #ARAStandards
-
In this MEDtalk, Astrid Damgaard presents a study that aimed to validate the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires (BRAF-MDQ and BRAF-NRS) for patients with spondyloarthritis. The results showed that these questionnaires are reliable and valid tools for measuring fatigue in this patient group, with good content validity, internal consistency, and test-retest reliability. #RheumatoidArthritis #SpA #Treatments
Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs
https://bpno.fi
-
In this MEDtalk, Astrid Damgaard presents a study that aimed to validate the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires (BRAF-MDQ and BRAF-NRS) for patients with spondyloarthritis. The results showed that these questionnaires are reliable and valid tools for measuring fatigue in this patient group, with good content validity, internal consistency, and test-retest reliability. #RheumatoidArthritis #SpA #Treatments
Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs
https://bpno.dk
-
In this MEDtalk, Astrid Damgaard presents a study that aimed to validate the Danish versions of the Bristol Rheumatoid Arthritis Fatigue Questionnaires (BRAF-MDQ and BRAF-NRS) for patients with spondyloarthritis. The results showed that these questionnaires are reliable and valid tools for measuring fatigue in this patient group, with good content validity, internal consistency, and test-retest reliability. #RheumatoidArthritis #SpA #Treatments
Measurement of Fatigue in Patients with Spondyloarthritis: Validation of the Danish Versions of the BRAFs
https://bpno.no
-
We’re on a mission to reduce the time-to-diagnosis for chronic and rare conditions like Psoriatic Arthritis (PsA) and Axial Spondyloarthritis (AxSpA). Through our wide-reaching partnership with Novartis, we’ve brought our AI-powered symptom assessment to multiple countries, helping hundreds of thousands of patients better understand their symptoms and access care. Learn how this partnership is helping patients living with these rheumatological conditions: https://bit.ly/47YfhJo
Raising awareness of chronic rheumatic disorders | Ada
ada.com
-
Our latest paper summary by Di Muzio, et al., “The Effects of Suppressing Inflammation by Tofacitinib may Simultaneously Improve Glycaemic Parameters and Inflammatory Markers in Rheumatoid Arthritis Patients with Comorbid Type 2 Diabetes: A Proof‑Of‑Concept, Open, Prospective, Clinical Study”, was a six-month study of 40 #RA patients with type 2 diabetes. They found a reduction of glycaemic parameters and significant improvements in RA disease activity. You can find the full paper summary on the IMID Forum completely free along with the latest updates in #RhematoidArthritis ➡️ https://lnkd.in/e-qJvMhy
-
-
Official Page of the Director of the Center for Evidence and Practice Improvement (CEPI) at Agency for Healthcare Research and Quality
Hear Jinoos Yazdany, M.D., M.P.H., discuss findings from a recent rheumatoid arthritis (RA) study during this AHRQ webinar on “Integrating Patient-Reported Outcomes into Clinical Practice,” offering insights into the benefits and unique challenges. Watch the on-demand webinar now to learn more! #PatientCare https://lnkd.in/eaF3jSTr
